TemporoMandibular Joint Disease Patient Registry Information Management System (TMD-PRIME) (TMD-PRIME)

TemporoMandibular Joint Disease Patient Registry Information Management System (TMD-PRIME)
Enrolling By Invitation
18 years - 100 years
All
Phase N/A
300 participants needed
1 Location

Brief description of study

The TMD-PRIME study will be a repository for DNA, RNA, plasma, serum, bone, & tissue from patients enrolled at the Penn Center for Temporomandibular Joint Disease (TMD). TMD-PRIME will create a bio-specimen & data repository by integrating efforts of researchers focused on the study of causes, detection, treatment, & prevention of TMD. This will enable further exploration of solutions for individualized therapy in TMD patients & will optimize development of targeted and personalized therapies.

Detailed description of study

Blood, extra tissue and/or bone will be collected from consented patient participants of the Penn Center for Temporomandibular Joint Disease during an already scheduled blood draw and surgical procedure as part of the patient's clinical care. The extra tissue and or bone harvested will be collected by, processed, and stored in the Tumor, Tissue, and Biospecimen Bank (TTAB) for secondary research.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Temporomandibular Joint Disease,TMJ,jaw,Healthy
  • Age: 18 years - 100 years
  • Gender: All

Inclusion

  •  18 years and older
  • Able to provide Informed Consent

Exclusion

  •  17 years and younger
 

Updated on 23 Jan 2026. Study ID: 24-1336
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research